Disease/Infection News

RSS

New computer modeling systems to predict spread of SARS-CoV-2 virus

Joe Mihaljevic, mathematical epidemiologist and assistant professor in Northern Arizona University's School of Informatics, Computing, and Cyber Systems, is leading a new project to create computer modeling systems to predict outcomes of the spread of the SARS-CoV-2 virus, which causes COVID-19, across four northern Arizona counties--Coconino, Navajo, Apache and Mohave.

4 May 2020

A $10 million grant enables expansion of BCG vaccine trial against COVID-19

An A$10 million grant from the Bill & Melinda Gates Foundation will allow the Murdoch Children's Research Institute's clinical trial of the BCG vaccine against COVID-19 to extend to 10,000 healthcare workers across Australia, Spain and The Netherlands.

4 May 2020

News study focuses on the impact of COVID-19 pandemic on social contact in older adults

The impact of the COVID-19 pandemic on social contact, loneliness, wellbeing and physical activity in older adults will be the focus of a new University of Stirling study.

4 May 2020

Study defines new starting points for therapy and vaccine research on coronavirus

The SARS coronavirus 2 (SARS-CoV-2) infects lung cells and is responsible for the COVID-19 pandemic. The viral spike protein mediates entry of the virus into host cells and harbors an unusual activation sequence.

4 May 2020

Newly identified antibody prevents SARS-CoV-2 virus from infecting cultured cells

Researchers at Utrecht University, Erasmus Medical Center and Harbour BioMed (HBM) today reported that they have identified a fully human monoclonal antibody that prevents the SARS-CoV-2 (COVID-19) virus from infecting cultured cells.

4 May 2020

As lawmakers reconvene, not everyone agrees on COVID-only agenda

California lawmakers return to the Capitol this week to begin what they describe as necessary but painful negotiations to keep the state running and redirect dwindling funds to the costly coronavirus pandemic.

4 May 2020

TissueGnostics joins the global fight against infectious diseases

The world is facing an unprecedented challenge in form of SARS-CoV-2 / COVID-19, and TG stand strong to support the mankind and our research community!

From TissueGnostics 4 May 2020

COVID-plagued California nursing homes often had problems in past

When Jorge Newbery finally got through to his 95-year-old mother, Jennifer, on a video call April 18, she could barely talk or move and her eyes couldn't focus.

4 May 2020

As COVID-19 lurks, families are locked out of nursing homes. Is it safe inside?

Families are beset by fear and anxiety as COVID-19 makes inroads at nursing homes across the country, threatening the lives of vulnerable older adults.

4 May 2020

Number of COVID-19 cases diagnosed in Spain increases to almost 10% of the people infected

A multidisciplinary research group of the Universitat Politècnica de Catalunya · BarcelonaTech (UPC) and the Germans Trias i Pujol Research Institute (IGTP) have analysed the diagnostic delay between the development of symptoms of COVID-19 and the registration of a positive case in ten countries in the European Union.

4 May 2020

Study reveals variable sites in novel coronavirus SARS-CoV-2

Understanding the varying aggressiveness of SARS-CoV-2 may provide valuable data to trace its spread across populations. In the study, published on the preprint server BioRxiv, the researchers traced amino acid variants that possess high frequency in Europe, particularly in Italy, one of the hardest-hit countries.

4 May 2020

New antibiotic fights drug-resistant bacteria without notable toxic side-effects

Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.

4 May 2020

Eco-friendly technique could enable hospitals to produce hydrogen peroxide

A team of researchers has developed a portable, more environmentally friendly method to produce hydrogen peroxide. It could enable hospitals to make their own supply of the disinfectant on demand and at lower cost.

4 May 2020

AI-based technology could help accelerate clinical trials for glaucoma

The technology, supported by an artificial intelligence (AI) algorithm, could help accelerate clinical trials, and eventually may be used in detection and diagnostics, according to the Wellcome-funded study published today in Expert Review of Molecular Diagnostics.

4 May 2020

Scientists develop CRISPR-based test for SARS-CoV-2

Now, a team of scientists at the University of California Santa Barbara has developed a low-cost, rapid, and high-tech test that can detect SARS-CoV-2 effectively. They have developed a CRISPR-based test that is sensitive and effective as traditional tests.

4 May 2020

New project launched to reduce COVID-19 infection among emergency room workers

Dr. David Talan, professor of emergency medicine and medicine in the Division of Infectious Diseases at the UCLA medical school will lead the trial with co-principal investigator Dr. Nicholas Mohr, vice chair for research in the Department of Emergency Medicine at the University of Iowa.

4 May 2020

FDA approves SFU professor's invention to wean COVID-19 patients from ventilators

Simon Fraser University professor Andy Hoffer hopes the SFU spinoff company he founded, Lungpacer Medical Inc., will help save the lives of COVID-19 patients using mechanical ventilators--and get them off more quickly, so that more ventilators can be available for all critically ill patients.

4 May 2020

New initiative to speed up development and commercialization of COVID-19 testing technologies

UMass Medical School and UMass Lowell will perform a key role in a new National Institutes of Health initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies via their Center for Advancing Point of Care Technologies collaboration.

4 May 2020

Researchers examine role of immune response in COVID-19 patients

A new USC study suggests that temporarily suppressing the body's immune system during the early stages of COVID-19 could help a patient avoid severe symptoms.

4 May 2020

SARS-CoV-2 receptor ‘mimic' could prevent COVID-19

Researchers from Italy have developed an exciting new peptide drug that could potentially prevent the coronavirus from infecting people’s cells. The paper, published on the preprint server bioRxiv* in April 2020, describes a small molecule that can bind to and block the attachment site on the virus spike protein, preventing its entry into the host cell.

4 May 2020